Skip to main content
OpenTrials

Clinical trial condition

Bipolar I Disorder

Explore clinical trials studying Bipolar I Disorder. Study availability and eligibility vary by location and protocol.

110 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Bipolar I Disorder trial results

Completed

A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

NCT00094432

Conditions
Bipolar I Disorder, Consciousness Disorders, Mental Disorders, +6 more
Locations
  • Local Institution Mesa, Arizona, United States
  • Local Institution La Mesa, California, United States
  • Local Institution La Palma, California, United States
  • Local Institution Long Beach, California, United States
View all 40 locations
View Trial Details
Completed

Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder

NCT00227305

Conditions
Bipolar I Disorder, Mental Disorders, Schizophrenia, +1 more
Locations
  • Research Site Dothan, Alabama, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Cerritos, California, United States
  • Research Site Riverside, California, United States
View all 48 locations
View Trial Details
Completed

Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder

NCT00114686

Conditions
Alcohol Dependence, Alcohol-Related Disorders, Alcoholism, +4 more
Locations
  • Research Site Cerritos, California, United States
  • Research Site San Diego, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Jacksonville, Florida, United States
View all 38 locations
View Trial Details
Completed

Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed

NCT00618748

Conditions
Bipolar I Disorder
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hiroshima, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan
View Trial Details
Completed

Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

NCT00107731

Conditions
Bipolar Disorder, Bipolar I Disorder, Bipolar and Related Disorders, +2 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Beverly Hills, California, United States
  • Research Site Chula Vista, California, United States
  • Research Site Redlands, California, United States
View all 166 locations
View Trial Details
Completed

A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents

NCT00195780

Conditions
Bipolar I Disorder
Locations
  • PCSD Feighner Research San Diego, California, United States
  • PCSD Feighner Research San Marcos, California, United States
  • Altamonte Springs, Florida, United States
  • Segal Institute for Clinical Research Fort Lauderdale, Florida, United States
View all 29 locations
View Trial Details

Related conditions